VolitionRx Limited Net Fee Amt
VolitionRx Limited (VNRX) had Net Fee Amt of $538 as of 2026-08-28, per its S-3 filed 2026-08-28.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-08-28
- 2026-08-28: Net Fee Amt $538.00.
- 2026-08-21: Net Fee Amt $56.34.
- 2026-07-10: Net Fee Amt $593.64.
| Period end | Net Fee Amt |
|---|---|
| 2026-08-28 | $538.00 S-3 · filed 2026-08-28 |
| 2026-08-21 | $56.34 S-8 · filed 2026-08-21 |
| 2026-07-10 | $593.64 S-3 · filed 2026-07-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |